NetworkNewsBreaks – Trxade Group Inc. (TRXD) Ach
Post# of 174
(Total Views: 193)
Posted On: 10/31/2019 4:02:43 PM
NetworkNewsBreaks – Trxade Group Inc. (TRXD) Achieves Record Revenues in Q3 2019
Trxade Group (OTCQB: TRXD), an integrated pharma supply chain and care platform, today announced its financial results for its third quarter ended September 30, 2019, and provided a business update. Among the highlights, the company reported the following results for quarter ending September 30, 2019 as compared to quarter ending September 30, 2018: record revenue growth of 173% to $2.311 million; operating income growth of 94% to $177,853; seventh straight quarter of positive operating income; and shareholder equity increase to $3.89 million. “During the third quarter of 2019, we made excellent progress in our core proprietary B2B trading platform www.Trxade.com, which enables independent pharmacies to purchase drugs at discount prices compared to their primaries, enabling us to experience top and bottom line growth,” Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “Additionally, we are investing in core infrastructure for our B-to-C business in our wholesale, e-commerce and delivery capabilities as increasing pharmaceutical prices drive independent pharmacies, payors and consumers to be more aggressive in sourcing medication. Accordingly, I am optimistic that our new product lines will generate profitability.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group (OTCQB: TRXD), an integrated pharma supply chain and care platform, today announced its financial results for its third quarter ended September 30, 2019, and provided a business update. Among the highlights, the company reported the following results for quarter ending September 30, 2019 as compared to quarter ending September 30, 2018: record revenue growth of 173% to $2.311 million; operating income growth of 94% to $177,853; seventh straight quarter of positive operating income; and shareholder equity increase to $3.89 million. “During the third quarter of 2019, we made excellent progress in our core proprietary B2B trading platform www.Trxade.com, which enables independent pharmacies to purchase drugs at discount prices compared to their primaries, enabling us to experience top and bottom line growth,” Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “Additionally, we are investing in core infrastructure for our B-to-C business in our wholesale, e-commerce and delivery capabilities as increasing pharmaceutical prices drive independent pharmacies, payors and consumers to be more aggressive in sourcing medication. Accordingly, I am optimistic that our new product lines will generate profitability.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)